+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anti Tumour Necrosis Factor"

Investigation Report on China's Infliximab Market 2022-2031 - Product Thumbnail Image

Investigation Report on China's Infliximab Market 2022-2031

  • Report
  • July 2022
  • 40 Pages
  • China
From
Graft Versus Host Disease (GvHD) Treatment Market Forecast - Epidemiology & Pipeline Analysis 2022-2027 - Product Thumbnail Image

Graft Versus Host Disease (GvHD) Treatment Market Forecast - Epidemiology & Pipeline Analysis 2022-2027

  • Report
  • May 2022
  • 190 Pages
  • Global
From
Tumor Necrosis Factor Receptor Superfamily Member 4 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Tumor Necrosis Factor Receptor Superfamily Member 4 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 70 Pages
  • Global
From
Alofisel - Product Thumbnail Image

Alofisel

  • Report
  • August 2018
  • 21 Pages
  • Global
From
Immunology Drugs Market Report Suite for the United States - 2018-2024 - Product Thumbnail Image

Immunology Drugs Market Report Suite for the United States - 2018-2024

  • Report
  • April 2018
  • United States
From
Rheumatoid Arthritis Therapeutics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Rheumatoid Arthritis Therapeutics Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • September 2025
  • 96 Pages
  • Global
From
Psoriatic Arthritis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Psoriatic Arthritis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • January 2024
  • 85 Pages
  • Global
From
TNF Inhibitor Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

TNF Inhibitor Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • October 2023
  • 94 Pages
  • Global
From
Tumor Necrosis Factor Alpha Inhibitor Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Tumor Necrosis Factor Alpha Inhibitor Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2023
  • 107 Pages
  • Global
From
Tumor Necrosis Factor Inhibitors Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Tumor Necrosis Factor Inhibitors Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • September 2024
  • 101 Pages
  • Global
From
2025 Global Forecast for Anti-Tnf-A Monoclonal Antibody Market (2026-2031 Outlook)-High Tech Outlook Report - Product Thumbnail Image

2025 Global Forecast for Anti-Tnf-A Monoclonal Antibody Market (2026-2031 Outlook)-High Tech Outlook Report

  • Report
  • January 2025
  • 132 Pages
  • Global
From
Loading Indicator

The Anti Tumour Necrosis Factor (anti-TNF) market is a subset of the Immune Disorders Drugs market. Anti-TNF drugs are used to treat a variety of immune-mediated diseases, such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by blocking the action of TNF, a protein that is involved in inflammation and tissue destruction. Anti-TNF drugs are generally administered as injections or infusions, and are often used in combination with other medications. The anti-TNF market is highly competitive, with a number of companies offering products. These include AbbVie, Amgen, Janssen, Merck, Pfizer, and UCB. Each company has its own portfolio of anti-TNF drugs, and they are continually developing new products to meet the needs of patients. Show Less Read more